Hepatitis Still a Frustrating (Hepatitis C Treatment Options) Foe

Hepatitis Still a Frustrating Foe
Street.Com - Since March 14, three drugmakers, Human Genome Sciences ( HGSI :Nasdaq - news - research - Cramer's Take ), Idenix Pharmaceuticals ( IDIX :Nasdaq - news - research - Cramer's Take ) and Valeant Pharmaceuticals ( VRX :NYSE - news - research - Cramer's

MIGENIX to Present at BIO 2006
Genetic Engineering News - VANCOUVER , BC, and SAN DIEGO , CA, April 6 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, has been selected to present at the BIO 2006 Business Forum which

Cuban Combined Therapy Against Chronic Hepatitis C
Ahora.cu - A Cuban combination therapy for the treatment of chronic Hepatitis C is to be put on the market by the Heber Biotec S.A. company in Latin America, Asia, Africa, the Middle East and Europe, where this firm has registered the Heberon Alfa R (human